通過條件成 績 ：60 分
-
中國創新藥商機 兵家必爭 - 環球生技月刊
-
抗生素研發的創新－困境克服
-
原廠藥退出台灣是健保害的？ 台大醫：關鍵問題在食藥署 - 今周刊
-
神藥還是錢坑 - 環球生技月刊
-
賠錢生意沒人做：抗生素的研發困境 _ 元氣網
-
Chapter-4-Anticancer-Drugs-Acting-via-Radical-Species-Radiotherapy-and-Photodynamic-Therapy-of-Cancer_2015_Medicinal-Chemistry-of-Anticancer-Drugs-Sec
-
Chapter-5-DNA-Alkylating-Agents_2015_Medicinal-Chemistry-of-Anticancer-Drugs-Second-Edition-
-
Chapter-6-Anticancer-Drugs-That-Interact-with-the-DNA-Minor-Groove_2015_Medicinal-Chemistry-of-Anticancer-Drugs-Second-Edition-
-
Chapter-9-Anticancer-Drugs-Targeting-Tubulin-and-Microtubules_2015_Medicinal-Chemistry-of-Anticancer-Drugs-Second-Edition-
-
Chapter-4-Anticancer-Drugs-Acting-via-Radical-Species-Radiotherapy-and-Photodynamic-Therapy-of-Cancer_2015_Medicinal-Chemistry-of-Anticancer-Drugs-Sec
-
Chapter-5-DNA-Alkylating-Agents_2015_Medicinal-Chemistry-of-Anticancer-Drugs-Second-Edition-
-
Chapter-6-Anticancer-Drugs-That-Interact-with-the-DNA-Minor-Groove_2015_Medicinal-Chemistry-of-Anticancer-Drugs-Second-Edition-
-
Chapter-9-Anticancer-Drugs-Targeting-Tubulin-and-Microtubules_2015_Medicinal-Chemistry-of-Anticancer-Drugs-Second-Edition-
-
中國創新藥商機 兵家必爭 - 環球生技月刊
-
原廠藥退出台灣是健保害的？ 台大醫：關鍵問題在食藥署 - 今周刊
-
抗生素研發的創新－困境克服
-
神藥還是錢坑 - 環球生技月刊
-
賠錢生意沒人做：抗生素的研發困境 _ 元氣網
-
patrick4e_ch01 Hsu
-
patrick4e_ch02 Hsu
-
patrick4e_ch03 Hsu
-
patrick4e_ch04 Hsu
-
patrick4e_ch06 Hsu
-
patrick4e_ch07 Hsu
-
patrick4e_ch08 Hsu
-
patrick4e_ch09
- 課程介紹
- 課程安排
- 評論
